It has also been confirmed that polygala saponins have potential benefits in the treatment of learning and memory deficits in APP/PS1 transgenic AD mice, and their effects may be related to the reversal of AD pathology-induced neuronal apoptosis (Wang L. et al., 2019). This evidence concerns the gene PSEN1 and Alzheimer disease.